Source link : https://newshealth.biz/health-news/part-d-cancer-drug-launch-prices-soar-past-inflation/
TOPLINE: Launch prices for Medicare Part D anticancer drugs have risen sharply since 2012, with a mean increase of $1694 per year. In 2025, the observed prices were 15%-200% higher than expected if the increases were due to inflation alone, but the gap between observed and inflation-adjusted prices narrowed over the study period. METHODOLOGY: The […]
The post Part D Cancer Drug Launch Prices Soar Past Inflation first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-10 02:40:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8